The federal Food & Drug Administration could fully approve the two-dose Pfizer COVID-19 vaccine as early as Monday, according to multiple reports.
Pfizer, Moderna, and Johnson & Johnson are currently operating under "emergency use authorization" for their COVID vaccines.
Many health officials hope full authorization will help with vaccine hesitancy.
It could also lead to more vaccine mandates. Several universities said they would revisit the issue of a vaccine mandate after the COVID shot was fully approved.
Many school districts may also put the COVID vaccine on its list of required vaccinations after it's fully approved.
The FDA did not comment to the New York Times, which was first to report about the potential authorization.